Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
D000230:Adenocarcinoma / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D012673:Semustine / Q000009:adverse effects / Q000627:therapeutic use*
D009607:Nitrosourea Compounds; D012673:Semustine; D003520:Cyclophosphamide